Invus Global Management, LLC - 26 Sep 2025 SCHEDULE 13G Report for Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Raymond Debbane
Security
Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
TENX
Shares outstanding
4,544,053 shares
Disclosed Ownership
427,141 shares
Ownership
9.4%
Form type
SCHEDULE 13G
Filing time
02 Oct 2025, 17:04:59 UTC
Date of event
26 Sep 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Invus Global Management, LLC disclosed 9.4% ownership in Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX) on 26 Sep 2025."

Quick Takeaways

  • Invus Global Management, LLC filed SCHEDULE 13G for Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX).
  • Disclosed ownership: 9.4%.
  • Date of event: 26 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 02 Oct 2025, 17:04.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 8% 366,143 366,143 0 /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 8% 366,143 366,143 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 8% 366,143 366,143 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 8% 366,143 366,143 0 /s/ Raymond Debbane Raymond Debbane, President
Avicenna Life Sci Master Fund LP 1.3% 60,998 60,998 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Avicenna Life Sci Master GP LLC 1.3% 60,998 60,998 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer
Ulys, L.L.C. 1.3% 60,998 60,998 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 9.4% 427,141 427,141 0 /s/ Raymond Debbane Raymond Debbane

Sponsored